Fig. 6From: Evidence that a primary anti-viral stimulation of the immune response by OM-85 reduces susceptibility to a secondary respiratory bacterial infection in miceComparison of the efficacy of oral treatment with OM-85 on the morbidity of S. pneumoniae “primary infection” (a, b, and c) versus “super-infection”, i.e. post-influenza infection (d, e and f) in mice, treated with OM-85 or BLANC. The clinical score, body temperature and the body weight loss are on the ordinate and the days after the S. pneumoniae infection on the abscissa. Data are representative of various experiments including setting up for the models, with 5–6 mice per time pointBack to article page